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1. Introduction 
In the few last decades, cod liver oil (CLO) has 
received a fast interest in the industry of fats and oils 
because of its nutritional supplements and has made its 
renaissance (Olsen et al., 2005). It is estimated that the 
production of CLO is nearly 10,000 ton per year and is 
originally marketed as potential sources of vitamin A and 
vitamin D, either in pharmaceutical or food supplement 
products. CLO is also the rich sources of omega fatty 
acids, namely eicosapentanoic acid (EPA) and 
docosahexanoic acid (DHA) (Gunston, 2004). In 
pharmaceutical fields, CLO is persistently being sold as 
medicines or functional food oils, either in capsule or 
suspension formulations. Functional food oils are 
defined as oils which have potential positive effects on 
human health (Stark and Mahar, 2002). 
There are two types of cod, namely Pacific cod 
(Gadus macrocephalus Tilesius) and Atlantic cod (Gadus 
morhua L.). The oil production from all body cod is not 
common because of the low fat contained in cod, which 
is less than 1% for both cod species. However, the 
byproducts of codfish processing like liver are commonly 
extracted for their oils to produce CLO (Shahidi and 
Miraliakbari, 2006). Fish oil products based on natural 
fish oil or their derivatives are persistently being 
introduced on the market as functional foods (capsules) 
or medicines. Microencapsulated fish oil has been 
introduced for the enrichment of foodstuff, including 
Cod liver oil (CLO), currently, has attracted public awareness and 
researchers as functional food oils. It is predicted that CLO will experience 
a great market in the fats and oils industry. CLO has been known to have 
several biological activities and its price is much higher (10–15 times) than 
common edible oils, thus CLO is subjected to adulteration with lower 
priced oils, therefore its authentication is highlighted in this review. This 
article highlighted some of the reported activities of CLO like the 
prevention of coronary heart disease. In addition, physico-chemical 
properties of CLO were also described in this review. Some analytical 
methods, especially spectroscopy and chromatographic based techniques 
along with its variation have been used for authentication of CLO from oil 
adulterants.  FTIR spectroscopy along with multivariate calibrations have 
been reported to be used for authentication of CLO from animal fats and 
vegetable oils fruitfully. Because of its capability to separate specific 
components in CLO, chromatographic techniques are suitable for such 
authentication using specific markers.  
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bread, infant formulas, baby food, soups, and prepared 
food such as pizza (Aursand et al., 2007).  
The aroma and flavor of CLO vary from a soft 
sardine-like flavor to an intense odor of fish, depending 
on its quality. High quality of CLO is a pale-yellow, thin, 
oily liquid, having a little fishy and bland taste. For this 
reason, some flavoring agents such as citrus or mint 
essence were added to CLO in order to make it more 
palatable (Gunston, 2004). 
Several factors contributed to the nutritional and 
price values of CLO in the markets, namely the quality of 
raw material, species used, and processing history from 
extraction until storage. According to new EC 
regulations (Commission Regulation 1662/2006) as cited 
from Standal et al. (2008)  ‘‘raw material used for the 
preparation of fish oil for human consumption must 
derive from fishery products deemed fit for human 
consumption, be prepared in an approved establishment 
or vessel, and transported and stored in a hygienic 
condition’’. 
 
2. Physico-chemical properties of Cod liver oil 
Physico-chemical properties of edible fats and oils 
are important for characterization of fats and oils. 
Different physical and chemical parameters of edible fats 
and oils can be exploited for the monitoring the quality 
of oils (Ceriani et al., 2008). These physicochemical 
parameters include iodine value, saponification value, 
viscosity, density, and peroxide value, anisidine value, 
oxidation products, and volatile compounds (Mousavi et 
al., 2012). In addition, these physical values are also used 
for identification of fats and oils from adulteration 
practices. 
The fatty acid (FA) composition of CLO along with 
physical and chemical properties is compiled in Table 1. 
CLO contained high levels of long-chain n-3 FAs of cis-5, 
8, 11, 14, 17-eicosapentaenoic acid (EPA) and cis-4, 7, 10, 
13, 16, 19-docosahexaenoic acid (DHA). Zeng et al. (2010) 
have used liquid chromatography electrospray tandem 
mass spectrometry (LC–ESI-MS/MS) for the structural 
elucidation of triacylglycerol (TAG) in cod liver oil 
without the TAG fractionation during the sample 
preparation. Rohman et al. (2012) also investigated TAG 
composition of CLO using HPLC with refractive index 
detector. The TAG composition of CLO is compiled in 
Table 2. The TAG composition of CLO was further 
subjected to principal component analysis and the 
results showed that it is possible to discriminate CLO and 
adulterated CLO with soybean oil and seal oil (Figure 1). 
 
Table 1. Physical and chemical properties of cod liver oil (CLO)† 
Physical properties* Value 
Iodine value (mg I2/g) 
Slip point (oC) 
Saponification value (mg KOH/g) 
Refractive index 
162 (159 – 166) 
< 10 
186 (185 – 187) 
618 (615 – 621) 
Fatty acid scomposition Level (%) 
Saturated fatty acid (SFA) 
C14: 0 
C16: 0 
C18: 0 
ΣSFA 
Monounsaturated fatty acid (MUFA) 
C16:1n-7 
C18: 1n-9 
C18: 1n-7 
C20: 1n-9 
C22: 1n-11 
C22: 1n-9 
ΣMUFA 
Polyunsaturated fatty acid (PUFA) 
C18: 2n-6 
C18: 3n-3 
C18: 4n-3 
C20: 5n-3 
C22: 5n-3 
C22: 6n-3 
ΣPUFA 
 
3.8 
9.4 
2.1 
15.3 
 
7.9 
17.1 
4.2 
10.9 
5.3 
0.5 
45.9 
 
1.8 
1.0 
3 
10.1 
1.2 
11.9 
27.2 
†*taken from Dreosti (1967); **taken from Brox et al. (2001). 
 
Table 2. Triacylglycerol (TAG) composition of cod liver oil 
(Rohman et al., 2012a). 
Triacylglycerol (TAG) Level (%) 
LLLn 0 
LLL 18.32 ± 1.26 
MOL 0 
OOL 2.95 ± 0.17 
POO 7.04 ± 0.49 
POL 1.55 ± 0.08 
PPO 3.24 ± 0.18 
MOP 3.42 ± 0.05 
PLP 3.43 ± 0.14 
OOO 5.78 ± 0.45 
POO 11.71 ± 0.80 
PLS 3.83 ± 0.31 
POP 7.34 ± 0.45 
POS 1.89 ± 0.06 
PPS 4.94 ± 0.21 
SOS 2.65 ± 0.30 
PSS 2.48 ± 0.10 
SSS 0.46 ± 0.25 
L = lauric; Ln = Linoleic; O = oleic; M = myristic; P = palmitic; S = 
stearic. Each value in the table represents the means of triplicate 
analysis; SD is given after ±
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Figure 1. The score plot of principle component analysis (PCA) model using triacylglycerolcompositions of cod liver oil (CLO) and animal fats. 
 
3. The biological activities of CLO 
Today, the considerable interest to consume 
several foods having the biological activities to treat and/ 
or to prevent certain diseases has appeared. Numerous 
studies have been explored to correlate the certain 
foods with its beneficial effects to human health, 
currently, known as functional food (Rohman and Che 
Man, 2012). CLO can be considered as functional food 
oils due to its ability to treat, promote, and prevent 
human health. It contained high levels of EPA and DHA 
which are believed to play an important role for the 
prevention of cardiovascular disease and for the 
alleviation of other health problems. In addition, the lack 
of these fatty acids (EPA and DHA) can result in the 
function impairment of numerous biological systems, 
including cardiovascular, nervous, immune, and skin 
(Moghadasian, 2008). 
 
3.1. CLO and coronary heart disease 
For many years, fish oils including CLO is associated 
with good health effects. The American Heart 
Association recommend to patients with coronary heart 
disease, the consumption of 1 g of fish oil per day, 
preferably by eating fish. The epidemiological studies 
also revealed that there is an inverse relationship 
between high fish oil consumption and the low mortality 
following coronary heart disease, possibly through the 
changes in prostaglandin metabolism (Weiner et al., 
1986; Jude et al., 2006).  
The consumption of CLO has the protective effect 
of coronary heart disease in a cohort of Norway men and 
women. The users of CLO had lower triglycerides (p < or 
= .05) than un-users. However, omega-3 fatty acid 
supplementation, provided no significant benefits to 
coronary heart disease, as practiced in this cohort study 
(Egeland et al., 2001).  The supplementation of CLO was 
also effective for preventing the cardiovascular disorders 
in streptozotocin (STZ)-diabetic rats. Besides, CLO also 
prevented the abnormalities of plasma lipid (Ceylan-Isik 
et al., 2007). 
The supplementation of CLO in human patient 
reduced the daily intake of non-steroid anti-
inflammatory drugs in order to attenuate the risks of 
gastrointestinal and cardiovascular adverse events 
associated with NSAIDS. CLO supplementation 
contatining n-3 fatty acids can be used as NSAIDs sparing 
agents in rheumatoid arthritis patiens (Galarraga et al., 
2008). 
 
3.2. CLO and anticancer 
Daily use of CLO was associated with reduced risk 
of death in patients with solid tumors (Skeie et al., 2009). 
The supplementation of CLO daily for at least a year in 
patients with solid tumors such as breast, colon, lung, 
but not blood cancers had a death risk of 33% less than 
those who used CLO less frequently, while patients with 
lung cancer, the mortality reduction was 44%. Vitamin D 
and omega-3 fatty acids in CLO contributed to lung 
cancer survival. 
 
3.3. Antidiabetic activity of CLO 
CLO was also reported to be correlated with the 
lower risk of diabetes mellitus insulin-dependent (Type 
I). These protective effects were caused by vitamin D or 
the omega-3 fatty acids of EPA and DHA present in CLO 
(Stene et al., 2000). Terkelsen et al. (2000) reported that 
CLO with dose 25% (wt/wt) in ointment preparation can 
significantly accelerate both the epithelial and the 
vascular component of healing compared with saline. 
This effect was contributed by the high vitamin A in CLO. 
Animals fed cod liver oil also demonstrated the reduced 
body weights (Karmazyn et al., 1987). However, vitamin 
A can accumulate in the body fat, and can reach harmful 
levels which are sufficient to cause hypervitaminosis of 
vitamin A and vitamin D. Overdoses of vitamin A and D is 
not desirable and must be avoided. 
Hunkar et al. (2002) have investigated the effect of 
CLO on streptozotocin (STZ)-induced-diabetic rats.  After 
12-week, in untreated rats, the levels of Plasma glucose, 
triacylglycerol and cholesterol were increased 
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significantly, while rats treated with CLO did not reveal 
abnormalities in cholesterol and triacylglycerol. Diabetic 
rats given with CLO also revealed better weight gain. 
The treatment of CLO also caused significant 
improvements in catalase activities in every tissue of 
diabetic rats. This study suggested that the treatment of 
CLO in diabetic rats provided better controlling in the 
metabolism of glucose and lipid. Because of the 
beneficial compounds contained, CLO provided 
important advantages to be used for the management 
of complications induced by diabetes. 
 
3.4. Hepatoprotective and neuroprotective activities of 
CLO 
CLO was reported to reveal hepatoprotective 
effects in Sprague Dawely rats (Salama et al., 2013). CLO 
reduced significantly hydrogen peroxide (H2O2), hepatic 
malondialdehyde, and superoxide anion. CLO restored 
hepatic cytochrome c oxidase activity after 38% 
reduction by sodium nitrite. In addition, CLO reduced 
hepatic MCP-1 (79.8 pg/mg) compared with sodium 
nitrite (168.7 pg/mg) and reduced DNA fragmentation 
(13.8%) compared with sodium nitrite (41.3%), 
significantly. CLO ameliorated sodium nitrite induced 
hepatic impairment through several mechanisms 
including attenuation of oxidative stress, blocking MCP-1, 
reactivation of mitochondrial function and reduction of 
DNA fragmentation. The dietary of CLO also revealed the 
protective effects toward inflammation on sodium 
nitrite-induced inflammation in rats.  
CLO reduced some tumor necrosis factor (TNF)-α, 
C-reactive protein (CRP), interleukin-1 beta (IL)-1β, 
transforming growth factor (TGF)-β1, and caspase-3 
compared to rats treated with sodium nitrite (Sherif and 
Al-Gayyar, 2014). 
CLO also revealed neuroprotective in male rat 
treated with neurotoxic agent of tartrazine. Rats given 
CLO at dose 0.4 mL/kg body weight exhibited the 
increased levels of different brain neurotransmitters, 
namely gamma amino butyric acid (GABA), dopamine 
(DA) and serotonin (5HT). These concentrations are 
reduced in rats treated with tartrazine. CLO also 
increased the concentrations of antioxidant biomarkers 
of catalase, super oxide dismutase, and the reduced 
glutathione. These results concluded that CLO offered 
the sufficient neuroprotective effects on rat pups brain 
tissue function and structure (Mohamed et al., 2015).  
 
3.5. CLO and obesity 
Recently, CLO which contain high amount of 
docosahexaenoic acid (DHA) is reported to be correlated 
with the activity reduction of stearoyl-CoA desaturase 
(SCD), enzyme which plays a crucial role in the 
development of obesity and insulin resistance in mice. It 
is hypothesized that dietary DHA contained in CLO may 
suppress SCD, and subsequently protect against the 
development of obesity and hypertriglyceridemia (Fujita 
et al., 2015). CLO was also reported to block the effects 
of sodium nitrite on glycogenesis and glycogenosis 
without affecting gluconeogenesis. Sodium nitrite can 
inhibit liver glycogenesis and enhance liver 
glycogenolysis and gluconeogenesis, which is 
accompanied by hyperglycaemia and insulin resistance 
through the activation of cAMP/PKA and the inhibition of 
phosphodiesterase (Al-Gayyar et al., 2015).  
 
3.6. Antiulcer activity  
Poly-unstaurated fatty acids in CLO was 
reported to inhibit the development of gastric ulcers 
induced by indomethacin in rats (Manjari and Das, 2000). 
When rats treated with CLO, there was a decrease in the 
incidence of gastric ulcers which were associated with 
the changes of phospholipid fatty acid profile. Khare et 
al. (2008) also reported that CLO increased the healing 
process of gastric ulcers and prevented the 
development of duodenal ulcers in rats. This activity was 
dose-dependent in which high dose of CLO (1 g/kg, 
peroral) was more active than low dose (0.5 g/kg).  
However, in the stress condition, CLO is reported to 
inhibit arachidonic acid formation, and consequently 
decreased the production of cytoprotective 
prostaglandins which lead to the development of gastric 
ulcers (Bernhard et al., 1996).  
Beside some beneficial effects of CLO, numerous 
studies have reported that too much consumption of 
CLO can cause several risks, attributed from overdoses 
of vitamin A and D as well as from the exposure of 
possible toxic substances which may be present in CLO 
(Guillen et al., 2009). Some these substances are 
polybrominated diphenyl ethers, polychlorinated 
biphenyls, hexachlorobenzene, hexachlorocyclohexane 
isomers ( , , ), and chlorinated pesticides (Storelli et 
al., 2004), or heavy metals, such as cadmium, lead and 
mercury (Guallar et al., 2002). Recently, using headspace 
analysis followed by gas chromatography-mass 
spectrometry, Guillen et al. (2009) has reported the 
presence of the toxic compounds of 4-hydroxy-(E)-2-
hexenal, 4-oxo-(E)-2-hexenal, and 4,5-epoxy-2-heptenal 
in CLO. Recent studies also reported that CLO contained 
arsenolipid compounds, neamely dimethylarsinicacid, 
methyl arsonicacid (MA), dimethyl arsenopropanoic acid 
(DMAP) and dimethylarsenobutanoicacid (DMAB).  
These compounds have been used as markers in human 
exposure to arseno compounds (Amayo et al., 2014). 
 
4. Authenticaton and discrimination of CLO 
CLO has high price value in the industry of fats and 
oils. As a consequence, some researchers have 
developed analytical methods for detection and 
quantification of adulterants in CLO. The most reported 
methods are spectroscopy and chromatography along 
with its variation. Due to its property as fingerprint 
technique, Fourier transform infrared (FTIR) 
spectroscopy is widely used for the authentication of 
CLO, especially in combination with multivariate 
calibration (Chemometrics) (Rohman, 2012).  For 
authentication purposes, the multivariate analysis used 
is multivariate calibration for quantitative purposes and 
pattern recognition for classification (Rohman and Che 
Man, 2012). 
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LO has the close similarity with lard. The presence 
of lard in any fats and oils is not allowed for muslim 
community, therefore the presence of lard in CLO must 
be detected for halal related issues. Rohman and Che 
Man (2009) have authenticated lard from CLO using FTIR 
spectroscopy combined with chemometrics of partial 
least square for quantification and discriminant analysis 
for classification. FTIR spectra at selected wavenumbers 
of 1035–1030 cm−1 is successfully optimized for 
developing the correlation between  actual value of lard 
(x-axis) and the FTIR-predicted value with coefficient 
determination (R2) value of 0.996 and root mean square 
error of cross validation (RMSECV) of 1.04% (v/v). While, 
the wavenumbers region of 1500–1030 cm−1, is 
successfully used for discriminating pure CLO and CLO 
mixed with lard.  
FTIR spectroscopy combined with chemometrics 
has been exploited to differentiate CLO from chicken fat 
(CF). Some frequency regions are optimized to analyse 
CF in CLO. Finally the wavenumbers region of 1500–900 
cm−1 was selected for this analysis. The root mean square 
error of calibration (RMSEC) value obtained was 0.346%. 
Using seven principle components, the RMSECV value 
obtained is 1.512%. The root mean square error of 
prediction (RMSEP) and R2 values for correlation 
between the actual and FTIR-predicted values of CF in 
CLO were 0.513% (v/v) and 0.998, respectively (Rohman 
and Che Man, 2011).  
The authentication of CLO from beef fat (BF) is 
performed by FTIR spectroscopy combined by fatty acid 
composition as determined by gas chromatography 
using flame ionization detector. FTIR spectroscopy 
combined with PLS at wavenumbers regions of 1200–
1000 cm-1 was used for the quantification of BF in CLO. 
The RMSEC and RMSEP values obtained are 0.55% and 
0.82% v/v, respectively. The decreased level of some fatty 
acids, especially eicosapentaenoic acid (EPA) and 
docosahexaenoic acid (DHA), could be used as a means 
for detecting adulteration of CLO from beef fat (Rohman 
and Che Man, 2011).  Mutton fat (MF) in CLO is analysed 
in the combined spectral regions of 3010–2995 and 
1500–900 cm−1. These regions provide the highest R2 
value (0.992) and the lowest RMSEC value (1.31%) 
compared with other spectral regions studied (Rohman 
et al., 2012). 
The presence of selected vegetable oils (canola, 
corn, soybean, and walnut) as adulterant oils in CLO has 
been analyzed using FTIR spectroscopy and multivariate 
calibration of PLS and discriminant analysis.  PLS with 
FTIR normal spectra was selected for quantification of 
these vegetable oils with an R2 higher than 0.99 and 
RMSEC in the range 0.04–0.82% (v/v). Disriminant 
analysis is successfully used for making classification of 
CLO and CLO mixed with these oil adulterants (Rohman 
and Che Man, 2011). 
Due to its capability as separation tools, 
chromatographic technique is used for identification of 
CLO by determining specific markers present in CLO 
(Chin et al., 2009).  Two dimensional gas 
chromatography coupled to time of flight mass 
spectrometry (GC x GC-TOF MS) is capable of identifying 
specific fatty acids which are absent in lard, beef fat, 
mutton fat and chicken fat. Such fatty acids are Methyl 
7,10,13-hexadecatrienoate (C16:3n-3), Methyl 9,12-
hexadecadienoate (C16:2n-4), Methyl 7-methylhexadece-
6-noate (7 m-16:1), Methyl 6,9,12,15-octadecatetraenoate 
(C18:4n-3), Methyl 6,9,12,15,18-heneicosapentaenoate 
(C21:5n-3), and Methyl 15-tetracosenoate (0.34 ± 0.15). 
 
5. Conclusion 
Cod liver oil has been recognized as functional food 
oils due to its beneficial effects to human health 
especially in prevention of coronary heart diseases, 
therefore CLO has high price value in the fats and oils 
industry. This attracted some unethical players to 
adulterate CLO with low price-oils. FTIR spectroscopy 
coupled with multivariate calibration as well as 
chromatographic techniques is successfully developed 
for identification of adulteration practices in CLO. 
Acknowledgement 
The authors thank to the Ministry of Research, 
Technology, and Higher Education for financial 
assistance during preparation of this manuscript. 
 
Reference 
Al-Gayyar, M.M.H., Alyoussef, A., Hamdan, A.M., Abbas, A., 
Darwiesh, M.M. and El-Hawwary, A.A. 2015. Cod liver oil 
ameliorates sodium nitrite-induced insulin resistance and 
degradation of rat hepatic glycogen through inhibition of 
cAMP/PKA pathway. Life Sciences 120: 13–21. 
Amayo, K.O., Raab, A., Krupp, E. and Feldmann, J. 2014. 
Identification ofarsenolipids and their degradation 
products in cod-liver oil. Talanta118: 217–223. 
Aursand, M., Standal, I.B. and Axelson, D.E. 2007. High-
Resolution 13C nuclear magnetic resonance spectroscopy 
pattern recognition of fish oil capsules. Journal of 
Agricultural and Food Chemistry 55: 38 – 47. 
Bernhard, W., Postle, A.D., Linck, M. and Sewing, K.F. 1996. Rat 
gastric hydrophobic barrier: Modulation of 
phosphatidylcholine molecular species by dietary lipids. 
Lipids 31: 507-511. 
Brox, J., Olaussen, K., Østerud, B., Elvevoll, E.O., Bjørnstad, E., 
Brenn, T., Brattebø, G. and Iversen, H. 2001. A long-term 
seal- and cod-liver-oil supplementation in 
hypercholesterolemic subjects. Lipids 36: 7 – 13. 
Ceriani, R., Paiva, F.R., Alves, C.B.G., Batista, E.A.C. and 
Meirelles, A.J.A. 2008. Densities and viscosities of 
vegetable oils of nutritional value. Journal of Chemical 
and Engenering Data 53(8): 1846–1853. 
Ceylan-Isık, A., Hünkar, T., Aşan, T., Kaymaz, F., Arı, N., 
Söylemezoǧlu, T., Renda, N., Soncul, H., Bali, M. and 
Karasu, C. 2007. Cod liver oil supplementation improves 
cardiovascular and metabolic abnormalities in 
streptozotocin diabetic rats. Journal of Pharmacy and 
Pharmacology 59: 1629–1641. 
Chin, S-T., Che Man, Y.B., Tan, C.P. and Hashim, D.M. 2009. 
Rapid Profiling of Animal-derived fatty acids using fast 
GCxGC coupled to time-of-flight mass spectrometry. 
Journal of the American Oil Chemists’ Society 86: 949 – 
958. 
Dreosti, G.M. 1967. Fish oil industry in South Africa and South 
West Africa. In Stands, M.E. (ed). Fish Oils: Their 
Chemistry, Technology, Stability, Nutritional Properties 
A. Rohman / J.Food Pharm.Sci (2017), 1  – 7                                                 5 
 
 
and Uses, p. 433 – 434. London: The Avi publishing 
company Inc.  
Egeland, G.M., Meyer, H.E., Selmer, R., Tverdal, A. and Vollset, 
S.E. 2001. Cod liver oil consumption, smoking, and 
coronary heart disease mortality: three counties, 
Norway. International journal of circumpolar health 
60(2):143-149.  
Fujita, Y., Okada, T., Abe, Y., Kazama, M., Saito, E. and 
Kuromori, Y. 2015. Effect of cod liver oil supplementation 
on the stearoyl-CoA desaturase index in obese children: A 
pilot study. Obesity Research and Clinical Practice 9: 31-
34.  
Galarraga, B., Ho, M., Youssef, H. M., Hill, A., McMahon, H., 
Hall, C.,  Ogston, S., Nuki, G. and Belch, J. J. F. 2008. Cod 
liver oil (n-3 fatty acids) as an non-steroidal anti-
inflammatory drug sparing agent in rheumatoid arthritis. 
Rheumatology (Oxford) 47(5): 665-669. 
Guallar, E., Sanz-Gallardo, M.I., Van’t Veer, P., Bode, P., Aro, A., 
Gomez-Aracena, J., Kark, J.D., Riemersma, R.A., Martin-
Moreno J.M. and Kok, F.J. 2002. Mercury, fish oils, and 
the risk of myocardial infarction. New England Journal of 
Medicine 347: 1747 – 1754. 
Guillén, M.D., Carton, I., Salmeron, J. and Casas, C. 2009. 
Headspace composition of cod liver oil and its evolution 
in storage after opening. First evidence of the presence 
of toxic aldehydes. Food Chemistry 114: 1291 – 1300. 
Gunston, F.D. 2004. The Chemistry of Oils and Fats: Sources, 
Composition, Properties and Uses. 1st ed. London: 
Blackwell Publishing Ltd. 
Hünkar, T., Aktan, F., Ceylan, A. and Karasu, C. 2002. Effects of 
cod liver oil on tissue antioxidant pathways in normal and 
streptozotocin-diabetic rats. Cell Biochemistry and 
Function 20:  297–302. 
Jude´, S., Roger, S., Martel, E., Besson, P., Richard, P., 
Bougnoux, P., Champeroux, P. and Le Guenne, J.Y. 2006. 
Dietary long-chain omega-3 fatty acids of marine origin: A 
comparison of their protective effects on coronary heart 
disease and breast cancers. Progress Biophysis and 
Molecular Biology 90: 299 – 325. 
Khare, S., Asad, M., Dhamanigi, S.S. and Prasad, V.S. 2008. 
Antiulcer activity of cod liver oil in rats. Indian Journal of 
Pharmacology 40: 209-214. 
Karmazyn, M., Horackova, M. and Murphy, M.G. 1987. Effects 
of dietary cod liver oil on fatty-acid composition and 
calcium transport in isolated adult rat ventricular 
myocytes and on the response of isolated hearts to 
ischemia and reperfusion. Canadian Journal of 
Physiological Pharmacology 65: 201 - 209. 
Manjari, V. and Das, U.N. 2000. Effect of polyunsaturated fatty 
acids on dexamethasone-induced gastric mucosal 
damage. Prostaglandines, Leukotrienes and Essent Fatty 
Acids 62: 85-96. 
Moghadasian, M.H. 2008. Advances in dietary enrichment with 
n-3 fatty acids. Critical Reviews in Food Science and 
Nutrition 48: 402 – 10. 
Mohamed, A.A., Galal, A.A. and Elewa, Y.H. 2015. Comparative 
protective effects of royal jelly and cod liver oil against 
neurotoxic impact of tartrazine on male rat pups brain. 
Acta Histochemica 117: 649–658. 
Mousavi, K., Shoeibi, S. and Ameri, M., 2012. Effects of storage 
conditions and PET packaging on quality of edible oils in 
Iran. Advances in Environmental Biology 6(2): 694–701. 
Olsen, E., Vogt, G., Saarem, K., Greibrokk, T. and Nilsson, A. 
2005. Autoxidation of cod liver oil with tocopherol and 
ascorbyl palmitate. Journal of the American Oil Chemists’ 
Society 82: 97 – 103. 
Rohman, A. and Che Man, Y.B. 2009. Analysis of cod-liver oil 
adulteration using Fourier transform infrared (FTIR) 
spectroscopy. Journal of the American Oil Chemists’ 
Society 86: 1149–1153. 
Rohman, A. and Che Man, Y.B. 2011. Analysis of chicken fat as 
adulterant in cod-liver oil using FTIR spectroscopy and 
chemometrics. CyTA Journal of Food 9(3): 187–191. 
Rohman, A. and Che Man, Y.B. 2011. Authentication analysis of 
cod liver oil from beef fat using fatty acid composition 
and FTIR spectra. Food Additives and Contaminants 
28(11): 1469–1474. 
Rohman, A. and Che Man, Y.B. 2011. Application of Fourier 
transform infrared (FT-IR) spectroscopy combined with 
chemometrics for authentication of cod-liver oil. 
Vibrational Spectroscopy 55: 141–145. 
Rohman, A. 2012. Application of FTIR spectroscopy for quality 
control in pharmaceutical products: a review. Indonesian 
Journal of Pharmacy 23(1): 1 -8. 
Rohman, A. and Che Man, Y.B. 2012. Application of Fourier 
transform infrared spectroscopy for authentication of 
functional food oils. Applied Spectroscopy Reviews 47(1): 
1-13. 
Rohman, A., Triyana, K., Sismindari, S. and Erwanto, Y. 2012. 
Differentiation of lard and other animal fats based on 
triacylglycerols composition and principal component 
analysis. International Food Research Journal 19(2): 475-
479. 
Rohman, A., Sunarminingsih, R. and Che Man, Y.B. 2012. The 
Employment of FTIR Spectroscopy and Chemometrics for 
Classification and Quantification of Mutton Fat in Cod 
Liver Oil. American Journal Food Technology 7(3): 151 - 
159. 
Salama, M.F., Abbas, A., Darweish, M.M., El-Hawwary, A.A. and 
Al-Gayyar, M.M.H. 2013. Hepatoprotective effects of cod 
liver oil against sodium nitrite toxicity in rats, 
Pharmaceutical Biology 51: 1435-1443. 
Shahidi, F. and Miraliakbari, H. 2006. Marine oils: compositional 
characteristics and health effects. In Shahidi, F. (ed). 
Nutraceutical and Specialty Lipids and Their Co-Products, 
p. 227 – 250. Boca Raton: Taylor and Francis Group.  
Sherif, I.O and Al-Gayyar, M..M. 2014. Cod liver oil in sodium 
nitrite induced hepatic injury: Does it have a potential 
protective effect? Communication in Free Radical 
Research 20: 11-16. 
Skeie, G, Braaten, T., Hjartaker, A., Brustad, M. and Lund, E. 
2009. Cod liver oil, other dietary supplements and 
survival among cancer patients with solid tumours. 
International Journal of Cancer 125: 1155-1160. 
Standal, I.B., Prae, A., McEvoy, L., Axelson, D.E. and Aursand, 
M. 2008. Discrimination of cod liver oil according to 
wild/farmed and geographical origins by GC and 13C NMR. 
Journal of the American Oil Chemists’ Society 85: 105 – 
112. 
Stark, R.D. and Madar, Z. 2002. Olive Oil as a Functional Food: 
Epidemiology and Nutritional Approaches. Nutrition 
Reviews 60(6): 170 –176. 
Stene, C., Ulriksen, J., Magnus, P. and Joner G. 2000. Use of cod 
liver oil during pregnancy associated with lower risk of 
Type I diabetes in the offspring. Diabetologia 43: 1093 – 
1098. 
Storelli, M.M. Storelli A. and Marcotrigiano, G.O. 2004. 
Polychlorinated biphenyls, hexachlorobenzene, 
hexachlorocyclohexane isomers, and pesticide 
organochlorine residues in cod-liver oil dietary 
supplements. Journal of Food Protection 67: 1787 – 1791. 
Terkelsen, L.H., Eskild-Jensen, A., Kjeldsen, H., Barker, J.H. and 
Hjortdal, V.E. 2000. Topical application of cod liver oil 
A. Rohman / J.Food Pharm.Sci (2017), 1 – 7                                                 6 
 
 
ointment accelerates wound healing: an experimental 
study in wounds in the ears of hairless mice. 
Scandinavian Journal of Plastic and Reconstructive 
Surgery and Hand Surgery 34: 15 - 20.  
Weiner, B.H., Ockene, I.S., Levine, P.H., Cuenoud, H.F., Fisher, 
M., Johnson, B.F., Daoud, A.S., Jarmolych, J., Hosmer, D. 
and Johnson, M.H. 1986. Inhibition of atherosclerosis by 
cod-liver oil in a hyperlipidemic swine model. The New 
England Journal of Medicine 315: 841 - 846. 
Zeng, Y-X., Araujoa, P., Du, Z-Y., Nguyen,T-T., Froyland, L. and 
Grung, B. 2010. Elucidation of triacylglycerols in cod liver 
oil by liquid chromatography electrospray tandem ion-
trap mass spectrometry. Talanta 82: 1261–1270. 
 
 
A. Rohman / J.Food Pharm.Sci (2017), 1 – 7                                                 7 
